Jounce Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

Shares

7,784

Value ($000)

14

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	14	0.0%	7,784	3/31/2023
2022 Q4	2/13/2023	0	0.0%	318	12/31/2022
2022 Q3	11/14/2022	1	0.0%	402	9/30/2022
2022 Q2	8/12/2022	2	0.0%	794	6/30/2022
2022 Q1	5/16/2022	397	0.0%	58,496	3/31/2022
2021 Q4	2/14/2022	564	0.0%	67,495	12/31/2021
2021 Q3	11/15/2021	1,424	0.0%	191,726	9/30/2021
2021 Q2	8/16/2021	985	0.0%	144,911	6/30/2021
2021 Q1	5/13/2021	2,495	0.0%	242,954	3/31/2021
2020 Q4	2/9/2021	788	0.0%	112,588	12/31/2020
2020 Q3	11/5/2020	753	0.0%	92,350	9/30/2020
2020 Q2	8/13/2020	576	0.0%	83,440	6/30/2020
2020 Q1	5/14/2020	351	0.0%	74,031	3/31/2020
2019 Q4	2/14/2020	490	0.0%	56,120	12/31/2019